| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BDX | Common Stock | Options Exercise | $565K | +3.83K | +13.25% | $147.68 | 32.7K | Aug 9, 2022 | Direct | |
| transaction | BDX | Common Stock | Disposed to Issuer | -$565K | -2.17K | -6.64% | $260.00 | 30.5K | Aug 9, 2022 | Direct | |
| transaction | BDX | Common Stock | Sale | -$430K | -1.65K | -5.41% | $260.00 | 28.9K | Aug 9, 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BDX | Stock Appreciation Rights | Options Exercise | $0 | -3.83K | -100% | $0.00* | 0 | Aug 9, 2022 | Common Stock | 3.83K | $147.68 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $260.00 through $260.03. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 12, 2022. |
| F2 | Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
| F3 | Award terms reflect adjustments made in connection with the spin-off of Embecta Corp. |
| F4 | The stock appreciation rights vest in four annual installments beginning November 26, 2016. |